At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory, 12 Week, Randomised, Partially Double-blinded, Placebo-controlled Parallel Group Trial to Explore the Effects of Once Daily Treatments of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination or Tiotropium (Both Delivered by Respimat® Inhaler), Supervised Exercise Training and Behavior Modification on Exercise Capacity and Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
In Brief
A Phase 3 clinical trial evaluating placebo to tiotropium + olodaterol, tiotropium+olodaterol, and 2 other interventions for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 304 participants across 34 sites in 11 countries.
Detailed Summary
The primary objectives of the study are to explore the effect of treatment with orally inhaled tiotropium + olodaterol fixed dose combination with and without exercise training, and tiotropium comparing to placebo, on top of behavioural modification in improving exercise capacity in patients with COPD
Study Details
Timeline
Interventions
comparator
tiotropium 5 mcg once daily
olodaterol 5 mcg once daily fixed dose combination
tiotropium 5 mcg once daily fixed dose combination